Lower drug prices, insurance premiums under Trump: White House economist Council of Economic Advisers acting chairman Tyler Goodspeed on President Trump’s economy and health care…
Read More
Study questions blood pressure drug guidance based on age and ethnicity
No evidence found to support differing advice according to age and ethnicity Current UK guidance on drug treatment for high blood pressure—which differs depending on…
Read More
Clinical trial shows experimental drug safely slows progression of diabetic kidney disease
The findings, simultaneously published in the New England Journal of Medicine and presented at the American Society of Nephrology’s Kidney Week 2020 conference, show the…
Read More
Lack of females in drug dose trials leads to overmedicated women
Women are more likely than men to suffer adverse side effects of medications because drug dosages have historically been based on clinical trials conducted on…
Read More
Drug for cancer treatment is effective against eye flu-timer Naturopathy naturopathy specialist portal
Arsenic trioxide against adenoviruses Adenoviruses can cause eye flu, gastro-intestinal disorders or lung inflammation. In most people, infection is relatively harmless, but in people with…
Read More
Popular chemotherapy drug may be less effective in overweight and obese women
Breast cancer patients who are overweight or obese might benefit less from treatment with docetaxel, a common chemotherapy drug, than lean patients. An international team…
Read More
Little evidence interventions prevent illicit drug use in youth
The U.S. Preventive Services Task Force (USPSTF) concludes that current evidence is inadequate for assessing the balance of benefits and harms of primary care interventions…
Read More
Anti-viral drug remdesivir effective against coronavirus, study finds
Anti-viral drug remdesivir cuts recovery times in coronavirus patients, according to the full results of a trial published Friday night, three weeks after America’s top…
Read More
New triple antiviral drug combination shows early promise for treating COVID-19 in phase 2 randomized trial
A two-week course of antiviral therapy with interferon beta-1b plus lopinavir-ritonavir and ribavirin, started within 7 days of showing COVID-19 symptoms, is safe and more…
Read More
More deaths, no benefit from malaria drug in VA virus study
A malaria drug widely touted by President Donald Trump for treating the new coronavirus showed no benefit in a large analysis of its use in…
Read More